GENB Generate Biomedicines, Inc.
Company Analysis
Latest News
🟢 Generate Biomedicines is trading 4.3% up today as Nasdaq Composite gains 1.09%
Generate Biomedicines is trading 4.3% up at $16.84 as the Nasdaq Composite gains 1.09% and technology and growth stocks lead a modest risk-on session. -...
🟢 Generate Biomedicines is trading 5% up in pre-market as Nasdaq Composite rises 0.94%
Generate Biomedicines is trading 4.89% up at $16.93, with the broader market supportive as the Nasdaq Composite rises 0.94%. - Shares declined 20.80% on...
🔴 Generate Biomedicines is trading 14.03% down today amid possible profit-taking or rally reversal
Generate Biomedicines is trading 14.03% down now at $17.52, with profit-taking or rally reversal suggested but unconfirmed. - It gained 15.01% to $20.38 on...
GENB Discloses Positive GB-0895 Data Supporting 6-Month Dosing for Asthma & COPD
Generate Biomedicines disclosed positive Phase 1 clinical trial data for its drug candidate, GB-0895, after posters for the European Respiratory Society...
🟢 Generate Biomedicines up 5% in pre-market ahead of lock-up expiration and upcoming clinical data
Generate Biomedicines is trading 5.25% up at $21.45, driven by anticipation of its August 26 post-IPO lock-up expiration and excitement for its upcoming...
🟢 Generate Biomedicines is trading 11.71% up today as biotech ETF XBI rises
Generate Biomedicines is trading at $19.80, up 11.71%, primarily on biotech-sector momentum. - The stock rose 9.93% on August 24, 2026, marking its second...
🟢 Generate Biomedicines is trading 4.5% up today amid biotech-sector momentum
Generate Biomedicines is trading 4.5% up now at $18.52, with the move appearing mainly supported by biotechnology-sector momentum rather than a confirmed...
🟢 Generate Biomedicines is trading 10.83% up today without a confirmed company-specific catalyst
Generate Biomedicines is trading 10.83% up now at $17.86, with no confirmed company-specific catalyst on August 24, 2026. - Its latest identifiable company...
🟢 Generate Biomedicines is trading 4.58% up today with no clear catalyst identified
Generate Biomedicines is trading 4.58% higher at $16.86, with no clear catalyst identified. - No new company-specific announcement, analyst action, or other...
🔴 Generate Biomedicines falls 4.2% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Generate Biomedicines is trading 7.7% up today after positive Moderna personalized cancer-vaccine trial results
Generate Biomedicines is trading 7.7% up now at $17.32 after biotechnology shares rallied broadly on positive Moderna personalized cancer-vaccine trial...
🟢 Generate Biomedicines is trading 4.62% up today; immediate cause unclear
Generate Biomedicines is trading at $16.41 (+4.62%), with the immediate cause unclear. - No clear company-specific announcement or filing dated August 18,...